Journal of Cardiac Failure
Volume 13, Issue 9 , Pages 722-731 , November 2007

Prospective Evaluation of Beta-Blocker Use at the Time of Hospital Discharge as a Heart Failure Performance Measure: Results From OPTIMIZE-HF

  • Gregg C. Fonarow, MD

      Affiliations

    • Department of Medicine, University of California Los Angeles Medical Center, Los Angeles, California
    • Corresponding Author InformationReprint requests: Gregg C. Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 LeConte Avenue, Room 47-123 CHS, Los Angeles, CA 90095-1679.
    • ,
  • William T. Abraham, MD, FACP, FACC,

      Affiliations

    • Division of Cardiology, The Ohio State University, Columbus, Ohio
    • ,
  • Nancy M. Albert, PhD, RN

      Affiliations

    • George M. and Linda H. Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Wendy Gattis Stough, PHARMD

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, North Carolina, and Department of Clinical Research, Campbell University School of Pharmacy, Research Triangle Park, North Carolina
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Barry H. Greenberg, MD

      Affiliations

    • Department of Medicine, UCSD Medical Center, University of California, San Diego, California
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Jie Lena Sun, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Clyde W. Yancy, MD

      Affiliations

    • Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas (Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas [current affiliation])
    • ,
  • James B. Young, MD

      Affiliations

    • Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • on behalf of the OPTIMIZE-HF Investigators and Coordinators

Received 22 January 2007 ,Revised 17 May 2007 ,Accepted 20 June 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The OPTIMIZE-HF registry is registered: www.clinicaltrials.gov, study number NCT00344513. The OPTIMIZE-HF registry and this study were funded by GlaxoSmithKline, Philadelphia, Pennsylvania.

PII: S1071-9164(07)00942-6

doi: 10.1016/j.cardfail.2007.06.727

Journal of Cardiac Failure
Volume 13, Issue 9 , Pages 722-731 , November 2007

Article Tools

* Image Usage & Resolution